Document 3296 DOCN M94A3296 TI Assembly of human immunodeficiency virus matrix protein. DT 9412 AU Morikawa Y; Kishi T; Nermut M; Hockley D; Jones I; Kitasato Institute, Tokyo, Japan. SO Int Conf AIDS. 1994 Aug 7-12;10(1):109 (abstract no. PA0056). Unique Identifier : AIDSLINE ICA10/94369279 AB OBJECTIVE: To investigate the oligomeric state of p17 matrix protein following expression in E. coli and recombinant baculoviruses. To identify the residues involved in oligomerisation and gag assembly. METHODS: p17 protein was expressed in E. coli and its oligomeric state was examined in vitro. Site-directed mutagenesis was used to modify cysteine residues in p17 and the mutant forms were similarly expressed and characterised. p17 mutations were also expressed in baculoviruses and their ability to assemble and secret antigen was assessed. RESULTS: Wild type p17 protein was found as monomer to hexamer forms on non-reducing SDS-PAGE. Mutations in either Cys57 to Ser or Cys87 to Ser led to the production of only monomers and dimers. Mutations in both residues prevented any oligomerisation. Expression of p17 in baculoviruses also showed oligomeric assembly to hexamers and was secreted. Cys mutations expressed in this system did not secret gag antigen. DISCUSSION AND CONCLUSIONS: p17 protein assembles to hexameric form via inter-subunit disulfide bond. The hexameric form may be the basic unit of gag assembly that leads to virion formation. DE Baculoviridae/GENETICS Escherichia coli/GENETICS Gene Expression Gene Products, gag/CHEMISTRY/GENETICS/*METABOLISM Human HIV/GROWTH & DEVELOPMENT/GENETICS/*METABOLISM HIV Antigens/CHEMISTRY/GENETICS/*METABOLISM In Vitro Mutagenesis, Site-Directed Protein Conformation Viral Matrix Proteins/CHEMISTRY/GENETICS/*METABOLISM MEETING ABSTRACT SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).